Literature DB >> 7884930

Papilloma formation in human foreskin xenografts after inoculation of human papillomavirus type 16 DNA.

J L Brandsma1, D G Brownstein, W Xiao, B J Longley.   

Abstract

A mouse model of high-risk human papillomavirus infection was developed in which human papillomavirus (HPV) type 16 DNA was inoculated into human foreskin grafted to the skin of severe combined immunodeficient (scid) mice. Grafted skin contained human epidermis and dermis and, like normal human skin, expressed involucrin in differentiating keratinocytes. HPV type 16 DNA, attached to gold particles, was delivered directly into human epidermal cells and induced exophytic papilloma with histologic features of papillomavirus infection, including koilocytosis and expression of papillomavirus capsid antigen. This model should be useful for determining in vivo the functions of viral genes and for developing strategies to prevent and treat HPV-associated disease. It may also be of value in developing animal models of other human skin diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7884930      PMCID: PMC188962     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

Review 1.  Control of papillomavirus gene expression.

Authors:  R Sousa; N Dostatni; M Yaniv
Journal:  Biochim Biophys Acta       Date:  1990-06-01

2.  Properties of a non-tumorigenic human cervical keratinocyte cell line.

Authors:  M A Stanley; H M Browne; M Appleby; A C Minson
Journal:  Int J Cancer       Date:  1989-04-15       Impact factor: 7.396

3.  Susceptibility of various human tissues to transformation in vivo with human papillomavirus type 11.

Authors:  J W Kreider; M K Howett; M H Stoler; R J Zaino; P Welsh
Journal:  Int J Cancer       Date:  1987-04-15       Impact factor: 7.396

4.  In vivo transformation of human skin with human papillomavirus type 11 from condylomata acuminata.

Authors:  J W Kreider; M K Howett; N L Lill; G L Bartlett; R J Zaino; T V Sedlacek; R Mortel
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Detection and typing of papillomavirus DNA in formaldehyde-fixed paraffin-embedded tissue.

Authors:  J L Brandsma; A J Lewis; A Abramson; M M Manos
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-07

6.  Human xenografts. A model system for human papillomavirus infection.

Authors:  M K Howett; J W Kreider; K D Cockley
Journal:  Intervirology       Date:  1990       Impact factor: 1.763

7.  Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice.

Authors:  M H Stoler; A Whitbeck; S M Wolinsky; T R Broker; L T Chow; M K Howett; J W Kreider
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

8.  Experimental infection with human papillomavirus type 1 of human hand and foot skin.

Authors:  J W Kreider; S D Patrick; N M Cladel; P A Welsh
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

9.  Genetic analysis of CRPV pathogenesis: the L1 open reading frame is dispensable for cellular transformation but is required for papilloma formation.

Authors:  M Nasseri; C Meyers; F O Wettstein
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

10.  Accell particle-mediated DNA immunization elicits humoral, cytotoxic, and protective immune responses.

Authors:  J R Haynes; D H Fuller; M D Eisenbraun; M J Ford; T M Pertmer
Journal:  AIDS Res Hum Retroviruses       Date:  1994       Impact factor: 2.205

View more
  8 in total

1.  Immunohistochemical analysis, human papillomavirus DNA detection, hormonal manipulation, and exogenous gene expression of normal and dysplastic human cervical epithelium in severe combined immunodeficiency mice.

Authors:  J A Taylor; K Tewari; S Y Liao; C C Hughes; L P Villarreal
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  High efficiency, long-term clinical expression of cottontail rabbit papillomavirus (CRPV) DNA in rabbit skin following particle-mediated DNA transfer.

Authors:  W Xiao; J L Brandsma
Journal:  Nucleic Acids Res       Date:  1996-07-01       Impact factor: 16.971

3.  Coinfection of human foreskin fragments with multiple human papillomavirus types (HPV-11, -40, and -LVX82/MM7) produces regionally separate HPV infections within the same athymic mouse xenograft.

Authors:  N D Christensen; W A Koltun; N M Cladel; L R Budgeon; C A Reed; J W Kreider; P A Welsh; S D Patrick; H Yang
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Production of infectious bovine papillomavirus from cloned viral DNA by using an organotypic raft/xenograft technique.

Authors:  A A McBride; A Dlugosz; C C Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

5.  Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis.

Authors:  Mathieu Nonnenmacher; Jérôme Salmon; Yves Jacob; Gérard Orth; Françoise Breitburd
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Isolation and propagation of human papillomavirus type 16 in human xenografts implanted in the severe combined immunodeficiency mouse.

Authors:  W Bonnez; C DaRin; C Borkhuis; K de Mesy Jensen; R C Reichman; R C Rose
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

7.  Influence of physiologic folate deficiency on human papillomavirus type 16 (HPV16)-harboring human keratinocytes in vitro and in vivo.

Authors:  Suhong Xiao; Ying-Sheng Tang; Rehana A Khan; Yonghua Zhang; Praveen Kusumanchi; Sally P Stabler; Hiremagalur N Jayaram; Asok C Antony
Journal:  J Biol Chem       Date:  2012-02-17       Impact factor: 5.157

8.  Photodynamic therapy of cottontail rabbit papillomavirus-induced papillomas in a severe combined immunodeficient mouse xenograft system.

Authors:  Richard G Lee; Mark A Vecchiotti; John Heaphy; Ashok Panneerselvam; Mark D Schluchter; Nancy L Oleinick; Pierre Lavertu; Kumar N Alagramam; James E Arnold; Robert C Sprecher
Journal:  Laryngoscope       Date:  2010-03       Impact factor: 3.325

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.